Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03348631
Title Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

endometrioid ovary carcinoma

endometrial adenocarcinoma

ovarian clear cell carcinoma

peritoneal carcinoma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.